$PBYI
PUMA BIOTECHNOLOGY, INC.

2012 Q2 Form 10-Q Financial Statement

#000119312512234886 Filed on May 15, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.770M $1.280M $0.00
YoY Change 5800.0%
% of Gross Profit
Research & Development $13.01M $10.57M $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $70.00K $50.00K $0.00
YoY Change
% of Gross Profit
Operating Expenses $14.78M $11.85M $3.942K
YoY Change 43025.64% 300559.56%
Operating Profit -$14.78M -$11.85M -$3.942K
YoY Change 43025.64% 300559.56%
Interest Expense $20.00K $30.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $23.00K $26.00K
YoY Change
Pretax Income -$14.75M -$11.83M $0.00
YoY Change 49066.67%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.75M -$11.83M -$3.942K
YoY Change 42958.51% 299900.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$736.0K -$590.3K $0.00
COMMON SHARES
Basic Shares Outstanding 20.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.00M $50.20M
YoY Change
Cash & Equivalents $41.00M $50.17M $0.00
Short-Term Investments
Other Short-Term Assets $800.0K $500.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $41.83M $50.71M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.228M $1.057M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.400M $1.100M
YoY Change
Total Long-Term Assets $2.608M $2.111M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $41.83M $50.71M
Total Long-Term Assets $2.608M $2.111M
Total Assets $44.44M $52.82M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.410M $566.7K
YoY Change
Accrued Expenses $13.13M $8.916M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.54M $9.483M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $900.0K $700.0K
YoY Change
Total Long-Term Liabilities $900.0K $700.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $15.54M $9.483M
Total Long-Term Liabilities $900.0K $700.0K
Total Liabilities $16.40M $10.23M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $64.86M $64.66M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.04M $42.60M
YoY Change
Total Liabilities & Shareholders Equity $44.44M $52.82M
YoY Change

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q1
OPERATING ACTIVITIES
Net Income -$14.75M -$11.83M -$3.942K
YoY Change 42958.51% 299900.0%
Depreciation, Depletion And Amortization $70.00K $50.00K $0.00
YoY Change
Cash From Operating Activities -$8.774M -$2.785M -$3.942K
YoY Change 21835.95% 70549.42%
INVESTING ACTIVITIES
Capital Expenditures -$240.0K $187.2K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$160.0K $0.00 $0.00
YoY Change
Cash From Investing Activities -$400.0K -$424.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 3.942K
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -8.774M -2.785M -3.942K
Cash From Investing Activities -400.0K -424.0K 0.000
Cash From Financing Activities 0.000 0.000 3.942K
Net Change In Cash -8.774M -3.209M 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$8.774M -$2.785M -$3.942K
Capital Expenditures -$240.0K $187.2K $0.00
Free Cash Flow -$8.534M -$2.972M -$3.942K
YoY Change 21235.95% 75297.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20040000 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9482779
CY2012Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8916099
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
537599
CY2012Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1053810
CY2012Q1 us-gaap Assets
Assets
52821686
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
2004
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
743706
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20040000 shares
CY2012Q1 us-gaap Assets Current
AssetsCurrent
50710861
CY2012Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
22065922
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50173262
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52821686
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
64659119
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
42595201
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20040000 shares
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1057015
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q1 us-gaap Liabilities
Liabilities
10226485
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
566680
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
586211
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
499542
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
281096
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1053284
CY2011Q4 us-gaap Assets
Assets
55398167
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
2004
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
439421
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20040000 shares
CY2011Q4 us-gaap Assets Current
AssetsCurrent
53662830
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
10239809
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53381734
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55398167
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
64610340
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
54372535
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20040000 shares
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
682053
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Liabilities
Liabilities
1025632
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
86669
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
6531
us-gaap Net Income Loss
NetIncomeLoss
-6931
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67022
CY2011 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
61983
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-10232878
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
7585600
CY2011 ck0001401667 Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
150000
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
68514
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
150000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2170269
us-gaap Investment Income Interest
InvestmentIncomeInterest
29419
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4616191
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
150000
us-gaap Share Based Compensation
ShareBasedCompensation
265082
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
675954
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9482779
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
7436319
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1053810
us-gaap Net Income Loss
NetIncomeLoss
-22065922
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50581
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11394754
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22065922
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
440505
us-gaap Depreciation And Amortization
DepreciationAndAmortization
59443
us-gaap Operating Income Loss
OperatingIncomeLoss
-22015341
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-675954
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56741208
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
50173262
us-gaap Operating Expenses
OperatingExpenses
22015341
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10561144
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56959722
ck0001401667 Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
67753
ck0001401667 Increase Decrease In Prepaid Expense And Other Assets
IncreaseDecreaseInPrepaidExpenseAndOtherAssets
537599
CY2011Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
3942
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3942
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-3942
CY2011Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3942
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3942
CY2011Q1 us-gaap Operating Expenses
OperatingExpenses
3942
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3942
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3942
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.001
CY2011Q1 ck0001401667 Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
4000000 shares
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
PUMA BIOTECHNOLOGY, INC.
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001401667
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
198060
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-424230
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
25636
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2784242
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
198060
CY2012Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
236533
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8896568
CY2012Q1 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
-149281
CY2012Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
526
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-11826113
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25636
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10568382
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
-149281
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11826113
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
187171
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
48741
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11851749
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-236533
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3208472
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
11851749
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1234626
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.590
CY2012Q1 ck0001401667 Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
67753
CY2012Q1 ck0001401667 Increase Decrease In Prepaid Expense And Other Assets
IncreaseDecreaseInPrepaidExpenseAndOtherAssets
256503
CY2012Q1 ck0001401667 Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
20040000 shares

Files In Submission

Name View Source Status
0001193125-12-234886-index-headers.html Edgar Link pending
0001193125-12-234886-index.html Edgar Link pending
0001193125-12-234886.txt Edgar Link pending
0001193125-12-234886-xbrl.zip Edgar Link pending
ck0001401667-20120331.xml Edgar Link completed
ck0001401667-20120331.xsd Edgar Link pending
ck0001401667-20120331_cal.xml Edgar Link unprocessable
ck0001401667-20120331_def.xml Edgar Link unprocessable
ck0001401667-20120331_lab.xml Edgar Link unprocessable
ck0001401667-20120331_pre.xml Edgar Link unprocessable
d329853d10q.htm Edgar Link pending
d329853dex311.htm Edgar Link pending
d329853dex312.htm Edgar Link pending
d329853dex321.htm Edgar Link pending
d329853dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending